Document:

EXHIBIT 10.7

                                    AGREEMENT

     This Agreement (this "Agreement") is made as of May 1, 2001, by and between
W. F. Young, Inc., a Massachusetts corporation having its principal office in
East Longmeadow, Massachusetts ("W.F, Young"); and NutraGlo, Inc., a Nevada
corporation having its principal office in Willows, California ("NutraGlo").
Wolcott Farms, Inc., a California corporation ('Wolcott Farms"), and NutraStar
Incorporated, a Nevada corporation, ("Nutrastar"), are signatories to this
Agreement for purposes of paragraphs (1)(D), (6)(E) and 11, 12, 13, 14, 15, 17
and 18 only-

                              PRELIMINARY STATEMENT

     NutraGlo has secured the exclusive right to use certain patents, trade
secrets, and other proprietary information (the "Technology'") used or useful in
the production of equine anti-inflammatory food supplements in all forms,
including but not limited to powder forms (the "Products"). The Technology and
the Products are more particularly described in Exhibit A, which is attached
hereto and made a part hereof. NutraGlo's business is to manufacture, package,
and ship items such as the Products. W. F. Young is experienced in the
manufacture and distribution of items such as the Products,

     Pursuant to the telalis, conditions and limitations set forth herein, the
parties hereto wish to establish a relationship pursuant to which;

     (A)     W, F. Young will be the exclusive worldwide distributor for the
Products;

     (B)     NutraGlo shall manufacture. package and ship all of W, F. Young's
requirements for the Products pursuant to the terms and conditions set forth
herein; and

     (C)     W. F. Young will have the right of first refusal to purchase the
Technology in the event the Technology is proposed to be sold by NutraGlo in the
future,

<PAGE>
     In consideration of mutual promises contained herein, the parties hereto
agree as follows:

     (1)  APPOINTMENT, TERRITORY AND STATUS OF THE DISTRIBUTORSHIP.

          Subject to the terms and conditions hereinafter set forth, NutraGlo
hereby appoints W. F. Young to be the sole and exclusive worldwide distributor
for the Products in all classes of trade and in all channels of distribution;
provided that the distributorship shall become non-exclusive in the event W.F.
Young fails to meet any of the minimum purchase requirements as set forth in
paragraph (1)(B), for any period set forth herein. In connection with W. F.
Young's appointment as distributor, the parties agree as follows:

          (A)     Sales Promotion. W. F. Young shall diligently and with all
                  ----------------
reasonable efforts promote the sale of the Products worldwide. The conditions
and methods for W. F. Young's promotion and sale o f the Products shall be
determined by W. F. Young in its sole discretion.

          (B)     Minimum Purchase Requirements. W.F. Young shall purchase the
                  ------------------------------
following minimum quantities of the Products: (i) 90,000 pounds on or before
July 1, 2001 (the "Initial Purchase Order"), (ii) an additional 120.000 pounds
before September I, 2002, (iii) 275,000 pounds between September 1, 2002 and
August 31, 2003. and (iv) 350,000 pounds between September 1, 2003 and August
31, 2004. For purposes of this Agreement, a "purchase" shall be deemed to have
occurred on the date that WY. Young makes payment on a Purchase Order.

          (C)     Minimum Purchase Orders. W.F. Young shall purchase the
                  ------------------------
Products in minimum quantities of 50,000 pounds.

          (D)     Referral of Orders. NutraGlo, Wolcott Farms, Inc., and/or
                  -------------------
Nutrastar, Inc., only shall sell the Products through W. P. Young, and any order
received by NutraGlo or Nutrastar shall be referred to W. F. Young.

                                        2
<PAGE>
          (E)     Term. The term of the distributorship granted hereunder shall
                  ----
be as set forth in paragraph (9)(A) below.

          (F)     Transactions and Orders. All transactions under this Agreement
                  ------------------------
shall be executed in accordance with individual contracts of sale between
NutraGlo and W. F. Young on a principal-to-principal basis. Neither party hereto
shall rescind or amend any order or individual contract of sale which has been
accepted by the other party without the written consent of the other party.

          (G)     Payment. Unless otherwise agreed by the parties in writing,
                  --------
payment by W. F. Young toNutraGlo shall . bemadeasfollows: (i) thirty percent
(30%) of the purchase price of each Purchase Order shall be paid at the time the
Purchase Order is accepted by NutraGlo, and ( ) seventy percent (70%) of the
Purchase Price of each Purchase Order shall be paid net ten (10) days after W.
F. Young's receipt of the Products, provided that NutraGlo shall provide W. F.
Young with a two percent (2%) cash discount.

     (2)  PRODUCT PRICING.

          (A)     Initial Price. The parties hereto agree that the price which
                  --------------
W. F. Young shall pay for the Products for orders placed before December 31,
2001, shall be equal to the sum of (i) $2.50 per pound (the "Material Price"),
(ii) the out-of-pocket cost of the packaging (unless W. F. Young, in its
discretion, purchases the packaging and has such packaging delivered to
NutraGlo). and (iii) the out-of-pocket cost of shipping the Products to the W.
F. Young distribution center (the "Product Price").

          (.B)     Price Changes On or before October 1st of each year, NutraGlo
                   --------------
may notify W. T. Young in writing of an adjustment to the Material Price for
orders received on January 1 of the following year through June 30th of the
following year. On or before March 31st of each year, NutraGlo may notify W. F.
Young in writing of an adjustment to the Material Price for orders received on
July 1st of the same year through December 31st of the

                                        3
<PAGE>
same year. The Material Price may be adjusted only (a) to reflect the per unit
increase or decrease in NutraGlo's direct cost for materials and components as
such relate to the manufacture of the Products; or (b) to reflect the per unit
increase or decrease in NutraGlo's reasonable increases in labor and overhead
costs as such relate to the manufacture of the Products. In the event that, for
the years beginning January 1, 2003 and January I, 2004 (and only for those
years), the increases of the Material Price under subparagraphs (i) and (ii)
above result in a Material Price increase of less than five percent (5%) over
the prior calendar year, NutraGlo may increase the Material Price up to the
difference between five percent (5%) and such increases effective January 1,
2003 or January 1, 2004, as the case nay be.

          (C)     All notices of a change in the Material Price shall be
accompanied by documentation sufficient to show the actual increases or
decreases in costs as set forth above. Further, W. F. Young may request that
NutraGlo provide further information to evidence such changes in costs. In the
event that W. F. Young or NutraGlo do not agree that a Material Price change is
warranted, the parties agree that the matter will be referred to a mutually
acceptable independent certified public accountant for final resolution.

     (3)  PACKAGING.

          The parties hereto agree that the Products shall be packaged in
accordance with the specifications set forth on Exhibit B, which is attached
hereto and made a part hereof. All changes to the packaging shall be subject tQ
the prior approval of NutraGlo, which approval shall not be unreasonably
withheld, Notwithstanding anything contained herein to the contrary, the parties
agree that all labels on the Products shall include a reference to NaeuralGlon,
NutraGlo(R) and Ri.ceX(R) and that Wolcott Farms, Inc. and NutraGlo, as the case
may be, hereby grant W. F. Young a non-exclusive license to use such terms and
all trademarks related thereto on all labels and advertising materials for the
Products during the term of this Agreement. The RiceX

                                        4
<PAGE>
Company shall provide W.F. Young with an acceptable non-exclusive license to use
RiceX(R) in the form described in Exhibit C, which is attached hereto and made a
part hereof. (4)

          INSPECTION AND TESTING.

          (A)     Tnspection. Before delivering the Products, NutraGlo shall
                  -----------
carefully inspect and test randomly selected samples from each batch for
compliance with specifications set forth on Exhibit D (the "Product
Specifications"), which is attached hereto and made a part hereof. NutraGlo, if
so requested by W. F. Young, shall give W. F, Young reasonable notice of the
making of such inspection or test and perrnit W. F. Young to be represented at
the testing. NutraGlo shall keep proper records of all such inspections and
tests and shall keep finished goods retain samples, stored at recognized room
temperature and humidity conditions, from each production batch for one (1) year
after the expiration date of said products or for three (3) years from the date
of production for those products not requiring expiration dating so that W. F.
Young can examine them when and if necessary. After the elapse of the
aforementioned period(s). NutraGlo shall ship the samples to W. F. Young,
freight collect, or after written authorization from W. F. Young, use other
legal means to dispose of the samples of production batches.

          (B)     Access. W. F. Young shall have the right at all reasonable
                  -------
times to inspect the Products during man.uf aeture or processing where
appropriate or while stored under the control of NutraGlo. If W. F. Young
exercises such right, NutraGlo shall afford access to such plant facilities as
may be reasonably necessary by W. F. Young.

          (C)     Recourse on. Defects. If, as a result of any inspection or
                  ---------------------
test of the Products by W. F. Young. on or before the expiration of stated shelf
life of such products, it is determined that the Products are not in accordance
with the Product Specifications as determined by a mutually acceptable third
party, W. F. Young may, without prejudice to any other provision. reject and
return the defective Products to NutraGlo at NutraGlo's expense and the Products

                                        5
<PAGE>
must, within a reasonable period of time to be agreed upon in writing by the
parties, be replaced by NutraGlo at its expense; provided, that NutraGlo is
given prior notice of the defective Products and a reasonable opportunity to
inspect the Products prior to the return to NutraGlo. In the event defective
Products are to be returned to NutraGlo, NutraGlo shall have the option to
direct the carrier on which the Products will be returned

     (5)   Representations and Warranties of W. F. Young.

           W. F. Young represents and warrants to NutraGlo as follows:

          (A)     Organization and Standing. It is a corporation duly
                  -------------------------
organized, validly existing and in good standing under the laws of the
Commonwealthof Massachusetts;

          (B)     Power and Authority. It has the power and authority to
                  --------------------
execute,  deliver  and  perform  this  Agreement  and  any Agreement executed in
connection herewith;

          (C)     Binding Agreement. This Agreement has been duly executed and
                  ------------------
delivered by W. F. Young and is the legal. valid and binding obligation of W. F.
Young, enforceable against W. F. Young in accordance with its terms, except as
enforcement may be limited by bankruptcy, insolvency, moratorium, reorganization
or other similar laws relating to or affecting the enforcement of creditors' ri
is generally, and except of the availability of specific performance, injunctive
relief or other equitable remedies as subject to the discretion of the court
before which any such proceeding therefore may be brought; and

          (D)     No Claim  to Technologv, It has no claim to the Technology or
                            --------------
the Products except as set forth in this Agreement.

      (6)  REPRESENTATIONS AND WARRANTIES OF NUTRAGLO.

           NutraGlo warrants to W. F. Young as follows:

          (A)     Organization and Standing. NutraGlo is a corporation duly
                  -------------------------
organized, validly existing and in good standing under the laws of the State of
Nevada. It has the power and authority to own and lease the properties now owned
or leased by it and to conduct its business.

                                        6
<PAGE>
          (B)     Power and Authority. It has the power and authority to
                  -------------------
execute, deliver and perform this Agreement and any Agreement executed in
connection herewith.

          (C)     Binding Agreement. This Agreement has been duly executed and
                  ------------------
delivered by NutraGlo and is the legal, valid and binding obligation of it and
enforceable against it in accordance with its terms, except as enforcement may
be limited by bankruptcy, insolvency, moratorium, reorganization or other
similar laws relating to or affecting the enforcement of creditors' rights
generally, and except of the availability of specific performance, injunctive
relief or other equitable remedies as subject to the discretion of the court
before which any such proceeding therefore may be brought.

          (D)     Warranty of Products. NutraGlo warrants that all Products sold
                  ---------------------
hereunder (i) shall be of merchantable quality, free from defects in materials
and workmanship and fit for their intended use, (ii) shall have a shelf life of
two (2) years following the delivery of the Products to W. F. Young and no more
than seven percent (7%) free fatty acid content at the end of such period,
provided that the Products are packaged in pre-approved, sealed containers and
stored in a cool, dry location, and (iii) shall be manufactured in accordance
with applicable Federal, State and local laws, regulations and orders.

          (E)     Warranty of Title. NutraGlo warrants that the Technology and
                  ------------------
the Products do not infringe on any United States or foreign patent, or on any
other right of any other person. NutraGlo indemnifies and holds W. F. Young
harmless against any claim of infringement of patent or such other rights
relating to the manufacture and the proper sale or proper use of the Technology
and/or the Products, and shall bear all costs of expenses, including reasonable
attorneys' fees arising from or related to any such claim; provided, that
NutraGlo shall have the right to choose mutually acceptable legal counsel in the
defense of any such claim As used herein, the term "claim" includes, without
limitation, any claim for any temporary or permanent injunctive relief of any
action for such infringement of patent or other such rights_

                                        7
<PAGE>
NutraStar warrants that they have exclusive rights to distribute nutraceutical
products containing RiceX M Stabilized Rice Bran for Animal and Human
industries.

          (F)     Warranty of Regulatory Compliance. NutraGlo represents and
                  ----------------------------------
warrants that the Products delivered to W. F. Young hereunder are fully
acceptable for use under the rules and regulations of the United States Food and
Drug Administration, United States Department of Agriculture and if applicable,
that the manufacture of the Products complies with the Federal Food, Drug and
Cosmetic Act of 1938, as amended, and all regulations and/or directives
hereunder; and are ly acceptable and comply with state and local governmental
regulations pertaining thereto.

     (7)     INDEMNIFICATION.

     Each party agrees to indemnify and hold the other party, its Directors,
officers and agents, harmless from and against all losses, damages, expenses,
and legal costs (including reasonable attorneys' fees) arising from breach of
this Agreement by the other party. NutraGlo shall maintain product liability
insurance with reputable and solvent insurance companies, providing protection
against any incidents or occurrences which may lead to claims, demands, causes
of action any other liabilities, including legal fees, caused by it or arising
out of an alleged failure of the Products to conform to or be manufactured in
accordance with the Product Specifications, in an amount not less than
$25,000.00 per claim, naming W. F. Young as an additional insured. Each party
shall provide the other party with a certificate of insurance to this effect,
and indicating that the other party will have thirty (30) days' prior written
notification of any termination, cancellation or amendment to such insurance
coverage. Notwithstanding anything contained herein to the contrary, neither
party shall be liable for indemnification pursuant to this Paragraph 7 unless
the claim at issue is equal to or exceeds Twenty-five Thousand Dollars
(525.000.00).

                                        8
<PAGE>
     (8)     RIGHT OF FIRST REFUSAL.

          In addition to any other right of W. F. Young to purchase the
Technology contained herein, in the event that NutraGlo determines to sell any
or all of its interests in the Technology during the term hereof to a third
party other than NutraStar or any of its affiliates or to Wolcott Farms or any
of its affiliates. For the purposes of this Section 8, "affiliate" shall mean
any entity which is either owned fifty percent (50%) or more by either/ or
NutraStar and Wolcott Farms, or which shares common ownership with either/ or
NutraStar and Wolcott /Farms. W. F. Young shall have the right to purchase the
Technology at the same price on the same terms and conditions as contained in
any bona fide third-party offer to purchase such interest within thirty (30)
days of delivery of NutraGlo's writtennotice thereof; which notice shall specify
the price, terms and conditions of the third-party offer, and the identity of
the offeror.

     (9)  TERM AND TERMINATION.

          (A)     Tenn, The initial term of this Agreement shall be for the
                  -----
three (3) year period, beginning on the date first written above and ending on
August 31, 2004; After the expiration of the initial term, this Agreement shall
automatically renew annually on. a calendar year basis for additional one (I)
year terms; provided. however, either party may elect to terminate this
Agreement for any reason after this Agreement has been in effect for at least
two (2) calendar years by giving six (6) months' written notice to the other
party prior to the automatic annual renewal. In the event of automatic renewal,
the minimum purchase requirement for the Products shall be 350,000 pounds per
I2-month period.

          (B)     Termination for Breach. In the event of a breach of this
                  -----------------------
Agreement. the non-breaching party shall have the right to terminate this
Agreement by written notice to the other party in the event that the breaching
party has failed to remedy a material fault after thirty (30) days' prior
written notice of such default. Notwithstanding anything contained herein to the
contrary, if for any reason NutraGlo is unable to supply W. F. Young's purchase
requirements of

                                        9
<PAGE>
the Products as set forth in paragraph (l)(B) herein during the term of this
Agreement (a "Supply Breach"), NutraGlo shall be responsible, within thirty (30)
days of written notice from W. F. Young for finding adequate replacement
capacity of stabilized rice bran and yucca of the same quality and
specifications required for W. F. Young to manufacture the Products or to have
the Products manufactured for W. F.Young, and in quantities sufficient for W.
l'. Young to manufacture the Products or to have the Products manufactured for
W. F. Young, with all costs of producing the Product (including the acquisition
of the stabilized rice bran and yucca) to be charged to NutraGlo. If adequate
replacement manufacturing capacity cannot be Found in such period of time, W. F.
Young may find replacement stabilized rice bran and yucca capacity on its own,
and charge any costs thereof to NutraGlo. In the event of a Supply Breach, W. F.
Young may opt to terminate this Agreement by written notice to NutraGlo and,
upon payment of all amounts due for Products ordered and delivered pursuant to
this Agreement, and upon payment of an amount equal to the amount set forth IN
Exhibit E, which is attached hereto and made a part hereof, W. F. Young shall be
able to purchase a license relating to the Technology, exclusive to the Equine
industry, as more fully set forth on Exhibit E.

          (C)     Mutual Termination. In the event that either party is unable
                  -------------------
to meet its obligations hereunder due to regulatory changes by any government or
other agency having authority over the Products, this Agreement shall terminate
upon written notice of one party to the other.

     (10) CONFIDENTIAL INFORMATION.

          (A)     The parties acknowledge that, by reason of the discharge of
their respective obligations pursuant to this Agreement, each party may be
exposed to, become aware of, or otherwise acquire a knowledge of certain
confidential and proprietary information of another party, including but limited
to information, documentation, software (including but not

                                        10
<PAGE>
limited to listings thereof and documentation related thereto). devices,
cuslonler lists, trade secrets and the like (the "Confidential Information").

          (B)     Each party acknowledges and agrees that the Confidential
Information of any other party is proprietary to such other party and
constitutes valuable trade secrets of such other party, and that any disclosure
or unauthorized use thereof will cause irreparable harm and loss to such other
party,

          (C)     Each party hereto agrees to treat the Confidential Information
of any other party in confidence and to undertake the following obligations with
respect thereto;

               (i )     To use the Confidential Information solely within the
scope of its proposed or continuing business relationship with such other party;

               (ii)     Not to copy, in whole or in part, the other party's
Confidential Information, except as may be required in the normal discharge of
its duties pursuant hereto;

               (iii)    Not to disclose, in whole or IN. part, the other party's
Confidential Information to any third party without the prior written consent of
the other party.

               (iv)     To limit the dissemination of the other party's
Confidential Information only to those employees or agents who have a need to
know in order to discharge such party's obligations hereunder; and

               (v)     To return any Confidential Information of another party,
including all copies and records thereof, to such othei party upon the other
party's written request, or the termination of this Agreement.

     The confidentiality provisions contained herein are in addition to terms of
a Mutual Non- Disclosure Agreement executed as of April 1, 1999, between and
among W. F. Young and Wolcott Farms, and a Mutual Non-Disclosure Agreement
executed as of April 18, 2001, between and among W. F. Young and Nutrastar. In
the event of a conflict between the terms of this Agreement and the Mutual
Non-Disclosure Agreement, the terms of this Agreement shall apply.

                                       11
<PAGE>
          (D)     The parties agree that each, from time to time, upon written
request of the other party, shall execute such documents or papers which Other
party may deem necessary for the protection of its interest in the Confidential
Information, including written assignments of patents, patents applications,
trademarks or other proprietary information or trade secrets to other party.

          (E)     The parties recognize that each is not employed by the other
and that each may have a variety of other independent business relationships
with other persons. The terms and conditions of this Agreement shall not apply
to any discoveries, improvements, patents or trade secrets developed, or
otherwise obtained in the course of such independent based business
relationships.

     (11) NON-COMPETITION.

          W. F. Young, NutraGlo. NutraStar Incorporated and Wolcott Farms, Inc.
agree that, during the term of this Agreement such parties will not, without the
other party's prior consent, which may be withheld for any reason, directly or
indirectly, alone or as a partner or joint venturer, director, employee,
consultant, agent or independent contractor of any entity or business, engage
in, or become involved in or assist any entity or business activity which is
directly or indirectly engaged in competition in the United States with the sale
of the Products in all classes of trade and in all distribution channels.

     (12) SURVIVAL.

          The restrictions and obligations of the parties under this Agreement
shall survive any expiration, termination or cancellation of this Agreement, and
shall continue to bind each party, successors, assigns, heirs, trustees, legal
representatives and administrators.

     (13) NON-WAIVER.

          No delay or failure by either party to exercise any right under this
Agreement

                                       12
<PAGE>
shall constitute a waiver of that or any other right, unless otherwise expressly
provided for herein.

     (14) SEVERABILITY.

          If any provision in this Agreement in any way violates the laws of any
state or jurisdiction, such provision shall be deemed not to be a part of this
Agreement in that jurisdiction, and the parties agree to remain bound by all
remaining parts hereof

     (15) SUCCESSOR AND ASSIGNS.

          This Agreement shall inure to the benefit and be binding upon the
parties hereto and their respective heirs, administrators, executors, successors
and assigns. The term "successor" shall include successors by merger or
acquisition, including sale of stock or sale of assets.

     (16) W. F. YOUNG AFFILIATES.

          The Parties agree that any rights granted W. F. Young hereunder may be
assigned, in whole or in part, from time to time, between and among W. F. Young
and any affiliates of W. F. Young. For purposes of this Section 16, "affiliate"
shall mean any entity which is either wholly owned by W. F. Young, or which
shares common ownership with W. F. Young.

     (17) ENTIRE AGREEMENT.

          Except as set forth in the Mutual Non-Disclosure Agreements, this
Agreement contains the entire Agreement of the parties hereto with respect to
the subject matter hereof, and no change or modifications hereo r shall be valid
unless made in writing, signed by all the parties hereto.

     (18) FORCE MAIEURE.
          --------------

     IF either party is rendered unable, in whole or in part, by force majeure
to carry out its obligations under this Agreement, other than the obligation to
make money payments, such party shall give the other party written notice within
ten (10) days of the force majeure, which written

                                       13
<PAGE>
notice shall describe fully the force majeure. The party claiming force majeure
shall use all reasonable diligence to remove the force majeure as quickly as
practicable. The requirement that any force majeure shall be remedied with all
reasonable dispatch shall not require the settlement of strikers, lockouts, or
other labor difficulties by the party involved, contrary to its business
judgment as determined in its sole discretion. As used herein, the term "force
majeure" shall mean circumstances beyond the reasonable control of the party
claiming force rriaj eure, which prevent that party from performing hereunder
and shall include, but not be limited to, fires, floods, strikes, lockouts or
other industrial disturbances, accidents, shipping difficulties, embargoes,
inadequate supply or labor or material, war, civil commotion, riots, acts of God
or of the public enemy, orders, requests, regulations, recommendations, or
instructions of any foreign or domestic government authority.

     (19) GOVERNING LAW, ARBITRATION,

          This Agreement shall be governed by and construed in accordance with
the laws of the State of California. The parties agree that any dispute
hereunder shall be settled by arbitration in New York, New York, pursuant to the
rules of the American Arbitration Association. Any arbitration ruling issued
pursuant to this Paragraph 17 may be enforced in any court of competent
jurisdiction.

                                       14
<PAGE>
     IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to
be executed by its duly authorized represcntative.

W. F. Young, Inc.                         NutraGlo, Inc.
By: Tyler F. Young                        By:

     1k9-                                 /s/  Patricia McPeak
     ----                                 ----------------------------------

Its:     Chaiiz~z , President CEO         Its:    5/D'e tIT     047' 0

                                     gRIPO"

WITH RESPECT TO PARAGRAPHS (1)(D), (f)(E), 11, 12, 13, 14, 15, 17 and 18 ONLY:

Nutrastar, Inc.                           Wolcott Farms, Inc.
By:                                       By:

/s/  Patricia McPeak
----------------------------------        ----------------------------------
Its  President & CEO                      Its

                                       15
<PAGE>
                                    EXHIBIT A
                           TECHNOLOGY AND THE PRODUCTS

               [CONFIDENTIAL TREATMENT REQUESTED FOR THIS EXHIBIT]

                                       16
<PAGE>
                                    EXHIBIT B

                            PACKAGING SPECIFICATIONS

     Packaging specifications for the first commercially available product
covered by this agreement are denotea by the following W.F. Young, Inc.
packaging spec. 4's:

Socc. #:               Desciption:
--------               -----------

315130                 PP Pail, 1 gallon, EZ STOP. with metal handle.

315131                 PP Lid, 1 gallon, EZ open hinged, Tamper Evident.

315135                 IIDPE Pail, 2 gallon, EZ STOR with metal handle.

315136                 PP Lid, 2 gallon, EZ open hinged, Tamper Evident.

                                       17
<PAGE>
                                    EXHIBIT C

               NON-EXCLUSIVE RIGHT TO USE RICEX TM Name and Logo.

     Letter from Daniel L. Mc.Peak, Sr., Chairman & CEO, RiceX Company to Harry
Hayes, W.P. Young, Inc., dated June 20, 2001 grants such rights and is hereby
incorporated into this agreement by reference.

                                       18
<PAGE>
                                    EXHIBIT D

                             PRODUCT SPECIFICATIONS

     The minimum Product Specifications are that the Products will have no more
than seven percent (7%) free fatty acid content and that the mold, yeast and
aerobic plate count are within industry standard specifications for human
consumption.

                                       I9
<PAGE>
                                    EXHIBIT E

                LICENSE FOR THE TECHNOLOGY - EXCLUSIVE FOR EQUINE

     Upon the satisfaction of the terms and conditions set forth in Section 9(B)
hereof and the payment of the License Fee (as defined below), NutraGlo shall
grant W.F. Young a perpetual license to the Technology - exclusive for Equine
only. The "License Fee" shall be calculated as follows:

     (a)  a one-time payment equal to the greater of $500,000 or the sum of the
          prior twelve month purchases by W.F. Young of the Products; and
     (b)  an on-going royalty payment equal to five percent (5%) of sales from
          products using the Technology (the "Royalties").

     The Royalties shall be paid on a calendar quarter basis on or before the
15calendar day of the month following the end of the attendant quarter. The
payment shall be accompanied by a report setting forth the sales activity by
product and the calculation of the Royalties (the "Royalty Report"), NutraGlo
shall have the right to audit a Royalty Report for one (1) year after its
delivery (the "Audit"). NutraGlo may use an independent certified public
accountant (the "Auditors") to conduct an Audit. Prior to its engagement, the
Auditors shall execute and deliver a confidentiality and non-disclosure
agreement containing usual and customary provisions protecting the W.F. Young.
The Auditors shall commence the Audit as soon as practicable and shall complete
the Audit and deliver their report to the parties as soon as practicable. The
parties shall use their best efforts to fully cooperate with the Auditors in its
conduct of the Audit. The Audit Report shall be conclusive and binding upon the
parties. provided that the parties may correct the Audit Report during the
fifteen (15)-day period following delivery thereof for any error as may be
agreed upon by the parties. If the Audit report determines that there is an
increase or decrease in the Royalties payable, then the W.F. Young shall pay the
NutraGlo the amount of the increase or NutraGlo shall pay the WY. Young the
amount of the decrease, as applicable, within fifteen (15) days after delivery
of the Audit report. NutraGlo shall pay the Auditors' fees and expenses of the
Audit; provided that if the Royalties reports under Audit understated the
Royalites payable by more than five percent (5%) in the aggregate, then WY.
Young shall pay the Auditors' fees and expenses of the Audit.

                                       20EXHIBIT 10.8

                              TECHNOLOGY AGREEMENT

     THIS  TECHNOLOGY  AGREEMENT  (the "AGREEMENT") is effective as of September
18,  2003  (the "Effective DATE") by and between NutraCea, Inc. flk/a NutraStar,
Inc.  (hereinafter  "NUTRACEA"),  a  California  corporation  having  a place of
business  at  1261  Hawks  Flight Court, El Dorado Hills, California 95762, W.F.
Young,  Inc.  ("WFY"),  a  Massachusetts  corporation with offices at 302 Benton
Drive,  East  Longmeadow  MA  01028,  and  Wolcott  Farms,  Inc.  ("Wolcott"), a
California  corporation  with  offices  at 315 West Sycamore Street, Willows, CA
95988.  NutraCea, WFY and Wolcott may hereinafter be individually referred to as
a  "PARTY"  or  collectively  as  the  "PARTIES".

     WHEREAS,  NutraCea  is  the  owner  of,  or  has  the right to use, certain
technology  related  to  the  manufacture  of  nutraceutical products containing
stabilized  rice  bran  and  stabilized  rice  bran  derivatives;

     WHEREAS,  WFY  is  a  leading  provider  of human and animal care products;

     WHEREAS,  NaturaiGlo  Specialty  Products,  LLC,  is  a  Delaware  limited
liability  corporation  to  be  jointly  owned  by  WFY  and  Wolcott;

     WHEREAS,  WFY  and  NutraGlo,  Inc.,  a  joint  venture between Wolcott and
NutraCea,  are parties to that certain distribution agreement dated May 1, 2001,
pursuant  to which, among other items, WFY was appointed the exclusive worldwide
distributor  of an equine anti-inflammatory food supplement formulation based on
NutraCea's  proprietary  technology  rights  (the  "DISTRIBUTION  AGREEMENT");

     WHEREAS,  Wolcott, WFY and NutraCea are parties to a letter of intent dated
September  18, 2003, pursuant to which the Parties desire to establish rights of
NGSP  in  and  to NutraCea's proprietary technology and to amend and clarify the
Parties'  rights  and obligations under the Distribution Agreement (the "LOII"),
pursuant  to  the  terms  and  conditions  of  this  Agreement.

     NOW,  THEREFORE,  in  consideration  of  the  foregoing  recitals,  and the
consideration  and  mutual  covenants contained herein, the sufficiency of which
are  hereby  acknowledged,  the  Parties  hereby  agree  as  follows:

1.   DEFINITIONS

For  purposes of this Agreement, the following terms have the meanings set forth
below.

     1.1  "AFFILIATE" means any person or entity directly or indirectly, through
one  or  more intermediaries, controlling, controlled by or under common control
with  the  applicable party. For purposes of this definition, the term "control"
(including  the terms "controlled by" and "under common control with") means the
possession,  direct  or  indirect,

<PAGE>
of  the power to direct or cause the direction of the management and policies of
a  person or entity, whether through membership, ownership of voting securities,
by  contract  or  otherwise.

     1.2  "CONFIDENTIAL  INFORMATION"  means  information in any form or medium,
that  is  either designated as proprietary and/or confidential by the disclosing
Party  or,  by  the nature of the circumstances surrounding disclosure, ought in
good  faith  to be treated as proprietary and/or confidential. Additionally, the
Licensed  Information  shall  be  considered  the  Confidential  Information  of
NutraCea.  Confidential  Information shall not include any information that: (i)
was  publicly  known  at  the  time of its receipt by the receiving Party or has
become  publicly  known  other  than  by a breach of this Agreement or any other
obligation  of  confidentiality;  (ii)  was already known by the receiving Party
prior to its disclosure, without obligation to keep it confidential, at the time
of  its receipt, as evidenced by prior documentation thereof; (iii) is developed
independently  by  the  receiving Party without use of or reference to the other
Party's  Confidential Information; or (iv) is received by the receiving Party in
good  faith from a third party lawfully in possession thereof without obligation
to  keep such information confidential and without requiring the receiving Party
to  keep  the  information  confidential.

     1.3     "FLEX  + PRODUCT" means the Product (as defined in the Distribution
Agreement).

     1.4  "INFORMATION"  means  trade secrets, know-how, documentation and other
technical  information proprietary to NutraCea and related to the development of
nutraceutical  products  containing  SRB  for  use  in  human  and  non-human
applications,  but  expressly  excluding  the  Patents.

     1.5  "PATENTS"  means U.S. Application No. 20030118672 entitled "Method for
Treating  Joint  Inflammation, Pain and Loss of Mobility", published on June 26,
2003,  and  assigned to NutraCea (the "APPLICATION"), any patents that may issue
from  the  foregoing  application,  all  continuations,  continuations-in-part,
reexaminations, divisionals, reissues, and improvements thereto, and any foreign
counterparts  to  any  of  the  foregoing.

     1.6     "TECHNOLOGY"  means  the  Information  and  the  Patents.

     1.7     "SRB"  means  stabilized  rice  bran  and  stabilized  rice  bran
derivatives.

     1.8     "Term" shall have the meaning ascribed to such term in Section. 8.1
hereof

2.   AMENDMENT AND CLARIFICATION OF DISTRIBUTION AGREEMENT

     2.1  The  Parties  hereby  agree to replace and restate Section 9(A) of the
Distribution  Agreement  by  extending  the  initial  term  of  the Distribution
Agreement  through September 17, 2006, subject to the earlier termination of the
Distribution  Agreement  as provided in Sections 9(B) and 9(C) thereof. This new
initial  term of the Distribution Agreement shall be automatically renewable for
additional  one  year  terms  by  WFY  upon  advance  written  notice

<PAGE>
by  WFY  to  NutraCea  no less than ninety (90) days prior to the end of the new
initial  term  or  any  renewal  term.

     2.2 The Parties agree NutraCea will retain its current production rights of
meal  and  pellet  forms of the Flex + Product in its 30 day and 60 day packages
through  September  I7,  2006. The .Parties further agree to replace and restate
WFY's  minimum  Flex  +  Product  purchase  requirements  under the Distribution
Agreement  by  requiring a new minimum Flex + Product purchase requirement of  *
over  the  remainder  of  the  term  of the Distribution Agreement (the "MINIMUM
PURCHASE  REQUIREMENT").

     2.3  Subject  to NutraCea's retained production rights set forth in Section
2.2  and  WFY's  rights  under the Distribution Agreement as amended herein, and
notwithstanding Section 3.1 below, NutraCea hereby assigns and transfers to NGSP
all rights related to the production and distribution of non-human nutraceutical
products  containing  SRB  that  are  created  using  the  Technology.

     2.4  In  exchange  for the modifications and amendments to the Distribution
Agreement  and rights granted to NGSP as set forth in this Article 2, WFY agrees
to  pay  to  NutraCea  the  sum  of  $  *  ("FLEX + PRICE"). NutraCea agrees and
acknowledges  its  receipt  of  $ * of the Flex + Price as of the Effective Date
(the  "INITIAL  FLEX  +  PAYMENF'). WFY agrees to pay the remaining $  *  of the
Flex + Price concurrently with the execution of this Agreement.

     2.5  The Parties agree the Flex + Price will be treated as a deposit on the
Minimum  Purchase  Requirement  and  will  be applied to the invoiced amounts in
partial  payment at the time of WFY orders for Flex + Product. The Parties agree
the  Flex  +  Product cost will remain at $ * per pound for the Minimum Purchase
Requirement  and  will thereafter be subject to the * % cost increase limits set
forth  in  the  Distribution  Agreement.  Any Flex + Product purchased after the
Effective  Date  shall  be applied against any outstanding commitments of WFY to
purchase  Flex  +  Product  under the Distribution Agreement as of the Effective
Date.

     2.6  The Parties agree to amend the Distribution Agreement to permit WFY to
utilize  a "human label" (as required under applicable provisions of the Dietary
Supplement Health and Education Act of 1994, as amended) in conjunction with the
distribution  of the Flex + Product for classes of trade that service the equine
industry  (e.g., farm, feed, tack stores, chain pet stores and printed or online
catalogs).

     2.7     Except  as  expressly  amended  by the terms of this Article 2, the
terms  and  conditions  of the Distribution Agreement shall remain in fall force
and  effect.

     "*"  REFERS  TO  PROPRIETARY  INFORMATION  FOR WHICH NUTRACEA IS REQUESTING
CONFIDENTIAL  TREATMENT

3.   TECHNOLOGY OPTIONS

     3.1  In  the event a U.S. patent issues from the Application, WFY will have
six  (6)

<PAGE>
weeks  from  the  date  of  such  issuance  in  which  to examine the patent and
determine,  in  its  sole  discretion,  whether it wishes NGSP to obtain certain
rights in the Technology. In the event WFY desires NGSP to obtain such rights in
the Technology, NutraCea hereby agrees to execute a technology license agreement
substantially  in  the  form  attached  hereto  as  Exhibit  A
                                                    ----------
     ("TECHNOLOGY  License  Agreement")  at  any  time  during  the Tenn of this
Agreement  within ten (10) business days of its receipt of such notice from WFY.

     3.2  NutraCea  represents  and  warrants  to WFY that it is engaged in good
faith  negotiations  with RiceX Company ("RiceX"), a Ieading manufacture of SRB,
whereby  NutraCea would acquire all shares or substantially all assets of RiceX.
In  connection  with  this  acquisition,  NutraCea  will clarify and confirm its
cun.ent exclusive right to manufacture and distribute, on a worldwide basis, all
nutraceutical  products containing RiceX brand SRB for human and non-human uses.
In  the  event  NutraCea  consummates  the  foregoing  acquisition  at  any time
following  the  Effective  Date,  NutraCea  will  immediately inform WFY of such
consummation  and  WFY  will have four (4) weeks from the date of such notice in
which  to  determine,  in  its sole discretion, whether it wishes NGSP to obtain
certain  rights  in the Technology. In the event WFY desires NGSP to obtain such
rights  in  the  Technology, NutraCea hereby agrees to assign to NGSP NutraCea's
exclusive  right  to  manufacture  and  distribute,  on  a  worldwide basis, all
nutraceutical  products containing RiceX brand SRB for non-human uses; provided,
however,  in  the  event NutraCea is manufacturing a "competitive" nutraceutical
product  containing  RiceX brand SRB for non-human use at the time WFY exercises
the foregoing option, then NutraCea will be the manufacturer of such product for
NGSP  for  as  long  as such product remains "competitive". For purposes of this
Section  3.2,  a  "competitive" nutraceutical product containing RiceX brand SRB
for  non-human  use  is  a  product  that  (a)  is  similar  to  a third party's
nutraceutical  product containing SRB, (b) is of same or better quality, and (c)
is  priced  at  no  more  than  *  % over the price to NGSP for such third party
product.

     3.3     To the extent WFY exercises either option set forth in Sections 3.1
or  3.2  above:

     (a)  WFY will pay to NutraCea a lump-sum fee of $ * (the "OPTION FEE"); and

     (b)  the  Parties  agree  and  acknowledge  that  the Flex + Price shall be
          deemed  a  deposit  against  the Option Fee; provided, however, if the
          Flex  Price has already been applied to the purchase of Flex + Product
          under  Sections  2.4  and 2.5 above, then WFY will not be permitted to
          offset  the  Flex  T  Price  against  the  Option  Fee.
  "*"  REFERS  TO  PROPRIETARY  INFORMATION  FOR  WHICH  NUTRACEA  IS REQUESTING
CONFIDENTIAL  TREATMENT

4.   CONFIDENTIALITY

     4.1     Neither  Party  shall  disclose  the  other  Party's  Confidential
Information  received  under  this  Agreement  to  any  third  party or use such
Confidential  Information  for  any purpose other than as expressly set forth in
this  Agreement.  Each  Party  shall  take  reasonable  measures,

<PAGE>
consistent  with those taken to protect its own Confidential Information, and in
no  event  less  than  commercially  reasonable  steps,  to  protect the other's
Confidential  Information  against disclosures in violation of this Agreement. A
Party may disclose Confidential Information to an employee or agent of the Party
who  must have such information to perform its obligations under this Agreement,
provided that such employee or agent has been advised of the confidential nature
of  the  information and is under an express written obligation to maintain such
confidentiality.  Any  and  all  reproductions  made by a receiving Party of the
disclosing  Party's  Confidential  Information  must  prominently  contain  a
confidentiality  legend.

     4.2  The  Parties  agree that a breach of the terms of this Article 4 would
result  in  irreparable  injury to the non-breaching Party for which a remedy in
damages  would  be  inadequate. The Parties agree that in the event of actual or
threatened  breach,  the  non-breaching  Party  shall  be  entitled  to  seek an
injunction to prevent such actual or threatened breach. Each Party will give the
other  written  notice  of  any  breach  by  such  Party  of any confidentiality
obligation  set  forth  in this Agreement as soon as such Party becomes aware of
the  breach.  Nothing  herein  shall  be construed as prohibiting the disclosing
Party  from  pursuing  any  other remedy available under this Agreement for such
actual  or  threatened  breach.

     4.3 Neither Party shall not in breach of this Agreement if it discloses the
other  Party's Confidential Information pursuant to an order of an United States
governmental  authority  or a court of competent jurisdiction; provided that the
receiving  Party  immediately  notifies the disclosing Party of such requirement
and uses best efforts to obtain confidential treatment of the disclosing Party's
Confidential  Information  by  the  agency  or  court.

     4.4  The  obligations  of  confidentiality set forth in the Article 4 shall
survive the termination or expiration of this Agreement. Nothing herein shall be
deemed  to  have  any  effect  on  the  protections  afforded  a Party under any
applicable  trade  secret  law,  or  other  law  that  purports  to  protect the
confidentiality  of  a  Party's  information.

5.   WARRANTIES

     5.1     Each  Party  represents  and  warrants  to the other that as of the
Effective  Date  it  has  full  right,  power  and  authority to enter into this
Agreement and to perform its respective obligations under this Agreement.

     5.2     NutraCea  represents  and  warrants  to  WFY  and  Wolcott  that:

     (a)  the  Technology  does not infringe on any patent or other intellectual
          property  right  of  any  third party, and does not misappropriate any
          trade  secrets  of  any  third  party;

     (b)  it  owns  or  has  the  right  to  use  the  Technology  in the nmrmer
          contemplated  by  the  Distribution  Agreement, this Agreement and the
          Technology  License  Agreement;

     (c)  it  has  the  right  to  grant  the  rights  in  and to the Technology
          contemplated  by  the  Technology  License  Agreement;

<PAGE>
     (d)  except as set forth our Exhibit B attached hereto, no person or entity
                                  ---------
          has  any  ownership  interest  in  or to the Technology or any portion
          thereof;  and  there  is  no  claim  or demand of any person or entity
          pertaining  to,  or  any  proceeding  which  is pending or threatened,
          against  NutraCea  or  any  Affiliate  of  NutraCea  in respect of the
          Technology.

     5.3  EXCEPT  AS  OTHERWISE  EXPRESSLY SET FORTH HEREIN, THE PARTIES MAKE NO
REPRESENTATIONS  OR  WARRANTIES  OF  ANY  KIND,  EITHER  EXPRESS OR IMPLIED, AND
EXPRESSLY  DISCLAIM  THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A
PARTICULAR  PURPOSE.

6.   INDEMNIFICATION

     6.1  Each  Party  agrees  to  defend, indemnify and hold harmless the other
Party  from and against any and all claims, demands, liabilities, losses, costs,
damages, fees or expenses (including attorneys fees) arising out of such Party's
breach  of  any of its representations, warranties, covenants or obligations set
forth  in  this  Agreement.

     6.2  A Party seeking indemnification in accordance with this Article 6 must
(a)  promptly  notify  the  indemnifying  Party  of  the  claim,  (b)  give  the
indemnifying  Party  full  opportunity  and  authority  to assume control of the
defense  or settlement of claims or suits, and (iii) furnish to the indemnifying
Party all information and assistance available for the defense. of such claim or
suit.

7.   LIMITATION  OF  LIABILITY

     7.1  Neither  Party  will  be  liable  to the other Party for any indirect,
actual,  special  or  consequential  damages  of  any kind or nature whatsoever,
including,  without  limitation,  lost profits, business interruptions, or other
economic  loss  arising  out  of  or  in  any  way  relating  to this Agreement.

     7.2 The limitation of liability set forth in Section 7.1 shall not apply to
a  Party's  indemnification  and confidentiality obligations hereunder or in the
event  of  gross  negligence  or  willful  misconduct  by  a  Party.

8.   TERM  AND  TERMINATION

     8.1  This Agreement shall commence on the Effective Date and continue until
the  later  of  WFY  exercise of either option under Sections 3.1 or 3.2, unless
sooner  terminated  in  accordance  with  the  provisions  set  forth below (the
"Term").

     8.2  Either  Party  may terminate this Agreement upon written notice if the
other  Party  fails to perform or abide by any of its material obligations under
this  Agreement, unless such default or breach has been cured within thirty (30)
days  of  written  notice  thereof  by  the  non-breaching  Party.

     8.3     The  Parties  may  mutually  agree  to  terminate this Agreement in
a  writing  signed

<PAGE>
by  duly  authorized  representatives  of  both  Parties.

     8.4     The  following  provisions  shall  survive  any termination of this
Agreement:  Articles  I,  2,  4,  5,  6,  7  and  9.

9.   MISCELLANEOUS

     9.1 NutraCea agrees that NGSP shall have the unrestricted right, subject to
the  mutual  agreement of WFY and Wolcott, to transfer this Agreement or any and
all  rights  NGSP  obtains  in  and  to  the  Technology  upon written notice to
NutraCea.  NutraCea  shall have no right to assign this Agreement, or any of its
rights  or  obligation  hereunder, to any third party without the consent of WFY
and  Wolcott  which  consent shall not be unreasonably withheld. Notwithstanding
the  foregoing,  NutraCea  shall  be  permitted  to  assign this Agreement to an
Affiliate  of  NutraCea or in connection with the transaction contemplated under
Section  3.2  hereof  Subject to the foregoing requirements of this Section 9.1,
this  Agreement  shall  be  binding  upon  and shall inure to the benefit of the
respective  Parties  hereto,  their  respective  successors-in-interest,  legal
representatives,  heirs  and  permitted  assigns.

     9.2     No  modification  of  this  Agreement  shall be effective unless in
writing  and  signed  by  the  Parties  hereto.

     9.3  All notices and other communications hereunder shall be in writing and
shall  be  sent  by  personal  delivery, registered or certified mail, overnight
delivery service, postage prepaid, or by facsimile with receipt of an electronic
delivery  confirmation,  addressed  as  follows:

     If  to  NutraCea:     NutraCea,  Inc.
                           1261 Hawk's Flight Court El
                           Dorado Hills, CA 95762
                           Phone: (916) 933-7000 Fax:
                           (916)  933-7001  Attention:
                           John  Howell

     If to WFY:            W.F. Young, Inc.
                           302 Benton Drive
                           East  Longmeadow,  MA  01028
                           Phone:  1  800  628-9653
                           Fax:  (413) 526-8990
                           Attention:  Tyler  Young

<PAGE>
     If to Wolcott:        Wolcott  Farms,  Inc.
                           315  West  Sycamore  Street
                           Willows,  CA  95988
                           Phone:  1  800  680-8254
                           Fax: 1 530 934-8370
                           Attention: Win Wolcott

Either Party may change its address for receiving notice by written notice given
to  the  other  Party. All notices shall be effective upon the earlier of actual
delivery  or  three (3) calendar days after deposit in the mail addressed as set
forth  above.

     9.4  This  Agreement  shall be governed by and construed in accordance with
the  laws  of  the  State  of  California.  The  Parties  agree that any dispute
hereunder shall be settled by arbitration in New York, New York, pursuant to the
rules  of  the  American  Arbitration Association. Any arbitration ruling issued
pursuant  to  the  Section  9.4  may  be  enforced  in  any  court  of competent
jurisdiction.

     9.5  If  any provisions of this Agreement shall be held unenforceable, such
holding  shall  not  affect the enforceability of any other provisions herein as
long  as  the  unenforceable  provision(s) does not materially affect the rights
granted  in  this  Agreement.

     9.6  Neither  Party  shall  be  responsible  for  delays  or  failures  in
performance  resulting  from  acts  beyond  their reasonable control, including,
without  limitation,  acts of God; strikes, riots, acts of war, epidemics, fire,
communication  line  failures,  earthquakes,  floods,  or  other  disasters.

     9.7  Failure of either Party to seek a remedy for the breach of any portion
of this Agreement by the other Party shall not constitute a waiver of its rights
with  respect  to  the  same  or  any  subsequent  breach.

     9.8  This  Agreement may be executed in any number of counterparts, each of
which,  when  so executed and delivered, shall be deemed an original, and all of
which  shall  constitute  one  and  the  same  Agreement.

     9.9 This Agreement shall be construed and interpreted fairly, in accordance
with  the  plain  meaning  of  its  terms,  and there shall be no presumption or
inference  against  the  party  drafting  this  Agreement  in  construing  or
interpreting  the  provisions  hereof.

     9.10     Each  Party  covenants  that  at  any time, and from time to time,
after  the  Effective Date, it will execute such additional instruments and take
such  actions  as  may  be reasonably requested by the other Party to confirm or
perfect  or  otherwise  to  carry out the intent and purposes of this Agreement,
including  without  limitation,  delivering the Technology License Agreement and
any  other  instruments  of  conveyance,  sale,  transfer  or  assignment.

     9.11  This  Agreement,  including  the  Exhibits  attached  hereto, and the
Distribution  Agreement  contain  the  entire understanding and agreement of the
Parties  with  respect  to  the

<PAGE>
subject  matter  hereof,  and  supersedes  any  prior written or oral agreements
between  them  with  respect  thereto  including,  without  limitation  the LOI.

     IN  WITNESS  WHEREOF,  the  Parties hereto have caused this Agreement to be
executed  by  their duly authorized officers as of the dates shown proximate the
execution  signatures  but  which  shall  have  the  Effective Date shown above.

<PAGE>
                     EXHIBIT A: TECHNOLOGY LICENSE AGREEMENT

     THIS  TECHNOLOGY  LICENSE AGREEMENT (the "Agreement") is entered into as of
200__  (the  "EFFECTIVE  DATE")  by  and  between  NutraCea,  Inc.  (hereinafter
"NUTRACEA"), a [CALIFORNIA] corporation having a place of business at 1261 Hawks
Flight  Court,  El  Dorado  Hills,  California  95762,  and NaturalGlo Specialty
Products,  LLC  (hereinafter  "NGSP"), a Delaware limited liability corporation.
NutraCea  and  NGSP  may hereinafter be individually referred to as a "PARTY" or
collectively  as  the  "PARTIES".

     WHEREAS,  NutraCea  is  the  owner  of,  or  has  the right to use, certain
technology  related  to  the  manufacture  of  nutraceutical products containing
stabilized  rice  bran  and  stabilized  rice  bran  derivatives;

     WHEREAS,  Natural  G1o  Specialty  Products,  LLC,  is  a  Delaware limited
liability  corporation  jointly  owned  by  W.F. Young, Inc. ("WFY") and Wolcott
Fauns,  inc.  ("WOLCOTT");

     WHEREAS,  WFY,  Wolcott and NutraCea are parties to that certain technology
agreement  dated  October  3, 2003 pursuant to which WFY has an option to obtain
certain  technology  rights  of  NutraCea  on  behalf  of  NGSP (the "TECHNOLOGY
AGREEMENT"),  pursuant  to  the  terms  and  conditions  of  this Agreement; and

     WHEREAS,  WFY  has exercised its option under Section 3.1 of the Technology
Agreement.

     NOW,  THEREFORE,  in  consideration  of  the  foregoing  recitals,  and the
consideration  and  mutual  covenants contained herein, the sufficiency of which
are  hereby  acknowledged,  the  Parties  hereby  agree  as  follows:

1.   DEFINITIONS

For  purposes of this Agreement, the following terms have the meanings set forth
below.

     1.1  "Affiliate" means any person or entity directly or indirectly, through
one  or  more intermediaries, controlling, controlled by or under common control
with  the  applicable party. For purposes of this definition, the term "control"
(including  the terms "controlled by" and "under common control with") means the
possession, direct or indirect, of the power to direct or cause the direction of
the  management  and policies of a person or entity, whether through membership,
ownership  of  voting  securities,  by  contract  or  otherwise.

     1.2  "CONFIDENTIAL  INFORMATION"  means  information in any form or medium,
that  is  either designated as proprietary and/or confidential by the disclosing
Party  or,  by  the nature of the circumstances surrounding disclosure, ought in
good  faith  to be treated as proprietary and/or confidential. Additionally, the
Licensed  Information  shall  be  considered  the  Confidential  Information  of
NutraCea.  Confidential  Information  shall  not  include  any

<PAGE>
information  that:  (i)  was  publicly  known  at the time of its receipt by the
receiving  Party  or  has  become  publicly known other than by a breach of this
Agreement  or any other obligation of confidentiality; (ii) was already known by
the  receiving  Party  prior  to  its  disclosure, without obligation to keep it
confidential,  at  the  time of its receipt, as evidenced by prior documentation
thereof,  (iii) is developed independently by the receiving Party without use of
or  reference to the other Party's Confidential Information; or (iv) is received
by  the  receiving Party in good faith from a third party lawfully in possession
thereof  without  obligation  to  keep such information confidential and without
requiting the receiving Party to keep the information confidential.

     1.3 "LICENSED INFORMATION" means trade secrets, know-how, documentation and
other  technical  information  proprietary  to  NutraCea  and  related  to  the
development  of  nutraceutical  products  containing  SRB  for  use in human and
non-human  applications  provided  by  NutraCea  to  NGSP  wider this Agreement,
including  without  limitation  the Licensed Information set forth in Schedule A
                                                                      ----------
attached hereto, but expressly excluding the Licensed Patents.

     1.4  "LICENSED  PATENTS"  means  U.S.  Application No. 20030118672 entitled
"Method  for  Treating Joint Inflammation, Pain and Loss of Mobility", published
on June 26, 2003, and assigned to NutraCea (the "APPLICATION"), any patents that
may  issue  from  the  foregoing  application,  all  continuations,
continuations-in-part,  reexaminations,  divisionals, reissues, and improvements
thereto,  and  any  foreign  counterparts  to  any  of  the  foregoing.

     1.5     "LICENSED  PRODUCT"  means  any  non-human  nutraceutical  product
containing  SRB  and  created  using the Licensed Information including, without
limitation  the  Flex  +  Product, the manufacture, use, sale or import of which
would  infringe  the claims set forth in the Licensed Patents. Licensed Products
may  be  created  in  any  form  including, without limitation, powder, pellets,
wafers  or  liquid.

     1.6     "LICENSED  TECHNOLOGY"  means  the  Licensed  Information  and  the
Licensed  Patents.

     1.7  "NET  SALES"  means  with  respect  to  a  Licensed Product, the gross
invoiced  price  paid  by  a  third  party  for  the  Licensed Product, less the
following  deductions  to  the  extent actually paid or allowed: (a) repayments,
allowances  or  credits  actually  given  to  such third parties for returned or
defective  Licensed  Products;  (b) freight, transportation, delivery, taxes and
insurance  costs  incurred  in transporting such Licensed Products to such third
parties  if  separately  itemized  on  the  invoice paid by the third party; (c)
sales, value-added, use and other direct taxes (other than income) to the extent
separately  stated  on purchase orders, invoices or other documents of sale; and
(d)  customs  and  tariff  duties  and surcharges and other governmental charges
incurred  in  connection  with  the  exportation  or importation of the Licensed
Products.

     1.8     "REPORTS"  shall  have the meaning ascribed to such term in Section
3.1  hereof

<PAGE>
     1.9     "ROYALTY  PAYMENTS" shall have the meaning ascribed to such term in
Section  4.1  hereof

     1.10  "Sale"  or "Sold" means the sale, lease, license, transfer, exchange,
or  other  disposition of Licensed Products whether by gift or otherwise. A Sale
shall  be  deemed consummated upon the first to occur of: (a) receipt of payment
from  the  purchaser;  (b)  delivery  of Licensed Products to the purchaser or a
common carrier; (c) if deemed sold by use, when first put to such use; or (d) if
otherwise  transferred, exchanged, or disposed of, whether by gift or otherwise,
when such transfer, exchange, gift, or other disposition occurs.

     1.11     "SRB"  means  stabilized  rice  bran  and  stabilized  rice  bran
derivatives.

     1.12     "TERM"  shall  have  the meaning ascribed to such term in. Section
10.1  hereof.

2.   TECHNOLOGY LICENSE GRANT

     2.1  Subject  to  the  terms  and  conditions  specified in this Agreement,
NutraCea  hereby  grants  to  NGSP  during the Term an exclusive, worldwide, and
in-evocable right and license to use the Licensed Technology to make, have made,
use,  sell, offer for sale, import, market and distribute the Licensed Products.

     2.2  The  Parties  agree  that  NGSP  is  granted only rights for non-human
applications  of the Licensed Technology and, unless otherwise set forth herein,
that  NutraCea  expressly  reserves  all  rights  for  human applications of the
Licensed  Technology.

     2.3 NGSP may retain third parties to assist in the development, manufacture
or  distribution  of  the  Licensed  Product,  provided  that  such  third party
contractor  sign  a  confidentiality  agreement containing substantially similar
terms  set forth herein protecting NutraCea's rights in the Licensed Technology.
NGSP  shall  remain  liable  to NutraCea for the acts and omissions of any third
party  contractor  it  retains.

     2.4  NutraCea  hereby  agrees NGSP may utilize a "human label" (as required
under  applicable  provisions of the Dietary Supplement Health and Education Act
of  1994,  as  amended)  in  conjunction  with  the distribution of the Licensed
Products  for  classes  of  trade  that service the equine industry (e.g., farm,
feed,  tack  stores,  chain  pet  stores  and  printed  or  online  catalogs).

3.   REPORTS AND RECORDS PAYMENT TERMS

     3.1  Within  forty-five  (45)  days  after the end of each calendar quarter
during  the  Term,  NGSP  shall  submit  to  NutraCea  a  written report (each a
"REPORT")  setting  forth  the following for the preceding Calendar Quarter: (a)
all  Sales of the Licensed Product; (b) a computation of the Net Sales price for
each  Sale;  and  (c)  a  computation  of the Royalty Payment payable hereunder.

<PAGE>
     3.2  During  the seven (7) year royalty term set forth in Section 4.1 below
and  for  a  period  of  one  (1)  year thereafter, NGSP shall keep complete and
accurate  records  of all Sales in accordance with generally accepted accounting
principles  and  in  sufficient  detail  to  enable  royalty  and other payments
required hereunder to be readily and accurately determined. During the seven (7)
year  royalty  term  set  forth in Section 4.1 below and for a period of one (1)
year  thereafter,  NutraCea  or  its  independent  auditor  shall have the right
annually  at  NutraCea's expense to review such records in the location(s) where
such  records  are  maintained by NGSP upon reasonable notice and during regular
business  hours  and  under obligations of confidence. If the review reflects an
underpayment  of  royalties  to NutraCea, such underpayment shall be immediately
remitted  to  NutraCea, together with interest calculated in the manner provided
in  Section  4.2.

4.   ROYALTIES;  PAYMENT  TERMS

     4.1  NGSP shall pay NutraCea a royalty equal to * percent (*%) of Net Sales
for  all  Licensed  Products  Sold  by NGSP or its agents for a period of  * (*)
years  from  the  Effective  Date  ("ROYALTY  PAYMENTS").

  "*"  REFERS  TO  PROPRIETARY  INFORMATION  FOR  WHICH  NUTRACEA  IS REQUESTING
CONFIDENTIAL  TREATMENT

     4.2 All payments due to NutraCea under this Agreement shall be made in U.S.
dollars  as follows: (i) for all Royalty Payments, on the date the corresponding
Report is due in accordance with Section 3.1; and (ii) for any other amounts due
hereunder, within thirty (30) days of the specified due date or invoice date. In
the event that NGSP fails to pay any amount when due, NutraCea may charge a late
fee equal to one percent (I%) per month (or, if less, the maximum amount allowed
by  applicable  law)  calculated on the number of days such payment is past die.
The  payment  of  such interest shall not foreclose NutraCea from exercising any
other  rights  it  may  have  because  any  payment  is  overdue.

5.   CONFIDENTIALITY

     5.1 Neither Party shall disclose the other Party's Confidential Information
to  any  third  party or use such Confidential Information for any purpose other
than  as expressly set forth in this Agreement. Each Party shall take reasonable
measures,  consistent  with  those  taken  to  protect  its  own  Confidential
Information, and in no event less than commercially reasonable steps, to protect
the  other's  Confidential  Information against disclosures in violation of this
Agreement. A Party may disclose Confidential Information to an employee or agent
of  the  Party  who  must have such information to perform its obligations under
this  Agreement,  provided  that  such employee or agent has been advised of the
confidential  nature  of  the  information  and  is  under  an  express  written
obligation to maintain such confidentiality. Any and all reproductions made by a
receiving  Party  of  the  disclosing  Party's  Confidential  information  must
prominently  contain  a  confidentiality  legend.

     5.2  The  Parties  agree that a breach of the terms of this Article 5 would
result  in

<PAGE>
irreparable  injury  to  the  non-breaching  Party for which a remedy in damages
would be inadequate. The Parties agree that in the event of actual or threatened
breach,  the  non-breaching  Party  shall  be  entitled to seek an injunction to
prevent such actual or threatened breach. Each Party will give the other written
notice  of  any breach by such Party of any confidentiality obligation set forth
in  this  Agreement  as  soon as such Party becomes aware of the breach. Nothing
herein  shall be construed as prohibiting the disclosing Party from pursuing any
other  remedy  available  under  this  Agreement  for  such actual or threatened
breach.

     5.3 Neither Party shall not in breach of this Agreement if it discloses the
other  Party's Confidential information pursuant to an order of an United States
governmental  authority  or a court of competent jurisdiction; provided that the
receiving  Party  immediately  notifies the disclosing Party of such requirement
and uses best efforts to obtain confidential treatment of the disclosing Party's
Confidential  Information  by  the  agency  or  court.

     5.4  The  obligations  of  confidentiality set forth in the Article 5 shall
survive the termination or expiration of this Agreement. Nothing herein shall be
deemed  to  have  any  effect  on  the  protections  afforded  a Party under any
applicable  trade  secret  law,  or  other  law  that  purports  to  protect the
confidentiality  of  a  Party's  information.

6.   PROPRIETARY RIGHTS

     6.1  NutraCea  shall  have  and  retain  full and complete ownership of the
Licensed  Technology  during the Term of this Agreement and thereafter, and NGSP
agrees  that  nothing  contained herein shall vest or otherwise give to NGSP any
right, title or interest in or to any of the Licensed Technology, other than the
license  granted  herein.

     6.2  NutraCea  retains the right in its sole discretion to seek, obtain and
maintain  patent  protection in the United States and in those foreign countries
deemed  appropriate  by  NutraCea  for the Licensed Technology. hi the case that
NutraCea does not seek patent protection, NGSP will have the right to pursue, at
its  expense,  such  protection in the United States and those foreign countries
deemed appropriate by NGSP. Such patents shall be assigned to NutraCea and shall
be  subject  to  alt  the  terms  and  conditions  of  this  Agreement.

     6.3  NutraCea  shall  be solely entitled to determine and carry out, in its
discretion, the course of action, if any, that may be appropriate for responding
to  instances  of  infringement  of  the  Licensed  Technology  or violations of
NutraCea's  or NGSP's rights with respect to the Licensed Technology, and except
as  provided  in  this  Article  6,  NutraCea  shall  have no obligation to NGSP
                        -----------
regarding  NutraCea's decision whether to take action or regarding any course of
action  NutraCea may choose to take, provided that NutraCea shall exercise sound
judgment  and  take  all reasonable care to protect and defend its rights in the
Licensed  Technology_ Where the third party infringement relates to the Licensed
Technology,  NutraCea may, at its own expense and in its own name, institute and
prosecute  any  actions  or proceedings or take other appropriate action against
third  parties  to  bring about discontinuance of such third party infringement.
NGSP  will  join  such  litigation  as  a named party, at NutraCea's request, if
necessary  to  the  litigation,  and  NGSP  will  provide  reasonable

<PAGE>
assistance  to  NutraCea  and  at  the  expense  of  NutraCea.

     6.4  If  NGSP  believes that additional or different action should be taken
against  infringement,  then  NGSP  may  so  notify  NutraCea in writing and, if
NutraCea  so  elects in NutraCea's sole discretion, NGSP may take action itself;
at  NGSP's  own expense. NutraCea will join such litigation as a named party, at
NGSP's  request,  if  necessary  to  the  litigation,  and NutraCea will provide
reasonable  assistance  to  NGSP,  and  at  the expense of NGSP. NGSP shall keep
NutraCea  reasonably  and  timely  informed of any action it takes hereunder and
shall  further  provide  NutraCea with such specific information as NutraCea may
require.  If  NGSP  takes action under such circumstances, NutraCea may elect at
any  time  to  resume responsibility, at NutraCea's expense, for carrying out or
disposing  of  such  action.

     6.5  NutraCea  will  retain  all proceeds from litigation prosecuted at the
expense  of  NutraCea.  NGSP will retain all proceeds from litigation prosecuted
solely  at  the  expense  of  NGSP.  The  parties agree to split all proceeds in
accordance  with the percentage of fees paid by each party where parties jointly
litigate  against  a  third  party  infringer.

     6.6  The  Parties agree and acknowledge the Licensed Technology consists of
"intellectual  property"  as  that  term is utilized under Section 365(n) of the
United  States Bankruptcy Act (the "Act"), and that NGSP is to receive and enjoy
the  benefits of a licensee of intellectual property under Section 365(n) of the
Act

7.   WARRANTIES

     7.1  NutraCea and NGSP each represents and warrants to the other that as of
the  Effective  Date  it  has full right, power and authority to enter into this
Agreement  and  to  perform  its  respective  obligations  under this Agreement.

     7.2     NutraCea  represents  and  warrants  to  NGSP  that:

     (a)  the  Licensed  Technology  does  not  infiiinge on any patent or other
     intellectual property right of any third party, and does not misappropriate
     any  trade  secrets  of  any  third  party;

     (b)  it  owns or has the right to use the Licensed Technology in the manner
     contemplated  by  this  Agreement;

     (c)  it has the right to grant the rights in and to the Licensed Technology
     contemplated  by  this  Agreement;

     (d)  except as set forth on Schedule B attached hereto, no person or entity
     ----------  has  any ownership interest in or to the Licensed Technology or
     any  portion  thereof;  and

     (e)  there  is no claim or demand of any person or entity pertaining to, or
     any  proceeding  which  is  pending  or threatened, against NutraCea or any
     Affiliate  of  NutraCea  in  respect  of  the  Licensed  Technology.

<PAGE>
     7.3  EXCEPT  AS  OTHERWISE  EXPRESSLY SET FORTH HEREIN, THE PARTIES MAKE NO
REPRESENTATIONS  OR  WARRANTIES  OF  ANY  KIND,  EITHER  EXPRESS OR IMPLIED, AND
EXPRESSLY  DISCLAIM  THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A
PARTICULAR  PURPOSE.

8.   INDEMNIFICATION

     8.1  NutraCea  agrees  to defend, indemnify and hold harmless NGSP from and
against  any  and all claims, demands, liabilities, losses, costs, damages, fees
or  expenses  (including attorneys fees) arising out of NutraCea's breach of any
of  its  representations, warranties, covenants or obligations set forth in this
Agreement.

     8.2  NGSP  agrees  to indemnify, defend and hold harmless NutraCea from and
against  any  and all claims, demands, liabilities, losses, costs, damages, fees
or  expenses (including attorneys fees) arising out of any of the following: (a)
any  unauthorized  use  of or infringement of the Licensed Technology by NGSP or
its employees, agents or third party contractors; and (b) any material breach of
this  Agreement  by  NGSP  or  its employees, agents or third party contractors.

     8.3  A Party seeking indemnification in accordance with this Article 8 must
(a)  promptly  notify  the  indemnifying  Party  of  the  claim,  (b)  give  the
indemnifying  Party  full  opportunity  and  authority  to assume control of the
defense  or settlement of claims or suits, and (iii) furnish to the indemnifying
Party  all information and assistance available for the defense of such claim or
suit.

     8.4 If the Licensed Technology furnished hereunder is threatened or held in
any  action  or  claim  to  constitute  an  infringement  of  a  third  party's
intellectual  property  rights,  NutraCea,  in addition to its other obligations
under  this  Article  S  and  at  its  sole  option  and  expense,  will:

     (a)  procure  for  NGSP the right to continue using the Licensed Technology
     hereunder;  or

     (b)  replace  or  modify  the  Licensed  Technology  with  a version of the
     Licensed  Technology  that  is  non-infiinging,

9.   LIMITATION  OF  LIABILITY

     9.1  Neither  Party  will  be  liable  to the other Party for any indirect,
actual,  special  or  consequential  damages  of  any kind or nature whatsoever,
including,  without  limitation,  lost profits, business interruptions, or other
economic  loss  arising  out  of or in any way relating to this Agreement or the
Licensed  Technology.

     9.2  Except  as  provided  in Section 9.3, in no event shalt either Party's
total,  aggregate  liability  for  any  proven, direct damages arising out of or
relating  to  this  Agreement  or  the  Licensed  Technology  exceed the Royalty
Payments  paid  by  NGSP  to  NutraCea  under  this

<PAGE>
Agreement.

9.3  The  limitation  of  liability  set forth in Sections 9.1 and 9.2 shall not
apply  to the Parties' indemnification and confidentiality obligations hereunder
or  in  the  event  of  gross  negligence or willful misconduct by either Party.

10.  TERM  AND  TERMINATION

     10.1 This Agreement shall commence on the Effective Date and shall continue
for  the  life  of  the  last issued Licensed Patent with regard to the Licensed
Patents,  unless  sooner  terminated in accordance with the provisions set forth
below  (the  "Term").

     10.2  Either  Party may terminate this Agreement upon written notice if the
other  Party  fails to perform or abide by any of its material obligations under
this  Agreement, unless such default or breach has been cured within thirty (30)
days  of written notice thereof by the non-breaching Party. NGSP's obligation to
make  Royalty  Payments  shall  be  deemed  a  material  obligation.

     103  The  following  provisions  shall  survive  any  termination  of  this
Agreement_  Articles  I,  3,  5,  6,  7,  8,  9,  10  and  i  1.
     11.  MISCELLANEOUS
     11.1  NutraCea  agrees that NGSP shall have the unrestricted right, subject
to  the  mutual  agreement of WFY and Wolcott, to transfer this Agreement or any
and  all  rights  NGSP  obtains  in  and to the Licensed Technology upon written
notice  to  NutraCea.  NutraCea shall have no right to assign this Agreement, or
any  of  its  rights  or  obligation  hereunder,  to any third party without the
consent of NGSP which consent shall not be unreasonably withheld. Subject to the
foregoing  requirements  of  this  Section 11.1, this Agreement shall be binding
upon  and  shall  inure  to  the benefit of the respective Parties hereto, their
respective  successors-in-interest,  legal  representatives, heirs and permitted
assigns.

     11.2     No  modification  of  this  Agreement shall he effective unless in
writing  and  signed  by  the  Parties  hereto.

     11.3 All notices and other communications hereunder shall be in writing and
shall  be  sent  by  personal  delivery, registered or certified mail, overnight
delivery service, postage prepaid, or by facsimile with receipt of an electronic
delivery  confirmation,  addressed  as  follows:

     If  to  NutraCea:        NutraCea,  Inc.
                              1261  Hawk's Flight Court El
                              Dorado I-lilis, CA 95762
                              Phone: (916) 933-7000 Fax:
                              (916)  933-7001
                              Attention:  John  Howell

<PAGE>
     if  to  NGSP:            W.F. Young, Inc.
                              302  Benton  Drive
                              East  Longmeadow,  MA  0102S
                              Phone:  1800  628-9653
                              Fax:  (413)  526-8990
                              Attention:  Tyler  Young

     and

                              Wolcott  Farris,  Inc.
                              315  West  Sycamore  Street
                              Willows,  CA 95988 Phone:
                              1 800 680-8254 Fax: 1 530
                              934-8370  Attention:  Win
                              Wolcott

Either Party may change its address for receiving notice by written notice given
to  the  other  Party. All notices shall be effective upon the earlier of actual
delivery  or  three (3) calendar days after deposit in the mail addressed as set
forth  above.

     11.4  This  Agreement shall be governed by and construed in accordance with
the  laws  of  the  State  of  Delaware.

      11.5 If any provisions of this Agreement shall be held unenforceable, such
holding  shall  not  affect the enforceability of any other provisions herein as
long  as  the  unenforceable  provision(s) does not materially affect the rights
granted  in  this  Agreement.

      11.6  Neither  Party  shall  be  responsible  for  delays  or  failures in
performance  resulting  from  acts  beyond  their reasonable control, including,
without  limitation,  acts of God, strikes, riots. acts of war, epidemics, fire,
communication  line  failures,  earthquakes,  floods,  or  other  disasters.

     11.7 Failure of either Party to seek a remedy for the breach of any portion
of this Agreement by the other Party shall not constitute a waiver of its rights
with  respect  to  the  same  or  any  subsequent  breach.

     11.8  This Agreement may be executed in any number of counterparts, each of
which,  when  so executed and delivered, shall be deemed an original, and all of
which  shall  constitute  one  and  the  same  Agreement.

     11.9  This  Agreement  shall  be  construed  and  interpreted  fairly,  in
accordance  with  the  plain  meaning  of  its  terms,  and  there  shall  be no
presumption or inference against the party drafting this Agreement in construing
or  interpreting  the  provisions  hereof.

     11.10  Each  Party covenants that at any time, and from time to time, after
the  Effective  Date,  it will execute such additional instruments and take such
actions  as may be reasonably requested by the other Party to confirm or perfect
or  otherwise  to carry out the intent and purposes of this Agreement, including
without  limitation, delivering any instruments of conveyance, sale, transfer or
assignment.

     11.11  This Agreement, including the Exhibits attached hereto, contains the
entire  understanding  and  agreement of the Parties with respect to the subject
matter  hereof,  and

<PAGE>
supersedes  any  prior  written  or  oral  agreements  between them with respect
thereto.

<PAGE>
     IN  WITNESS  WHEREOF,  the  Parties hereto have caused this Agreement to be
executed  by  their duly authorized officers as of the dates shown proximate the
execution  signatures  but  which  shall  have  the  Effective Date shown above.

<PAGE>
                   SCHEDULE A TO TECHNOLOGY LICENSE AGREEMENT

DESCRIPTION  OF  LICENSED  TECHNOLOGY:

1.     The  inventions,  processes  and  methods  covered  by  the claims of the
Licensed  Patents.

2.     The Equine-Anti-Inflammatory Field Study conducted by Dr. G. Kaufman from
August  to  October,  2000,  as  sponsored  by  WFY.

3.     [LIST  ANY  OTHER  FIELD  STUDIES,  MANUALS,  DOCUMENTATION.]

<PAGE>
                        SCHEDULE B TO TECHNOLOGY LICENSE

Agreement Third parties that have rights in the Licensed

Technology: [to be supplied by NutraCea]

<PAGE>
                                    EXHIBIT B

                         Claims in and to the Technology

Third parties that have rights in the Licensed

Technology: to be supplied by NutraCeal

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}]]